Borui Pharmaceuticals: Net profit of 54.5147 million yuan in 2025, down 71.18% year-on-year

Borui Pharmaceutical announced that in 2025, operating revenue will be 1.22B yuan, a year-on-year decrease of 4.59%. Net profit is 54.5147 million yuan, a year-on-year decrease of 71.18%. The company plans to distribute cash dividends of 0.16 yuan (including tax) for every 10 shares to all shareholders, based on the total share capital registered on the rights distribution record date minus the shares repurchased in the company’s dedicated repurchase account.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin